Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;52(4):992-998.
doi: 10.1007/s11239-021-02465-9. Epub 2021 May 22.

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests

Paul A Gurbel  1 , Udaya S Tantry  2 , Robert F Storey  3
Affiliations

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests

Paul A Gurbel et al. J Thromb Thrombolysis. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Gurbel reports grants and personal fees from Bayer HealthCare LLC, Otitopic Inc, Amgen, Janssen, and US WorldMeds LLC; grants from Instrumentation Laboratory, Haemonetics, Medicure Inc, Idorsia Pharmaceuticals, and Hikari Dx; personal fees from UpToDate; Dr Gurbel is a relator and expert witness in litigation involving clopidogrel; in addition, Dr. Gurbel has two patents, Detection of restenosis risk in patients issued and Assessment of cardiac health and thrombotic risk in a patient. Dr. Tantry reports receiving honoraria from UptoDate. RF Storey reports institutional research grants/support from AstraZeneca, Cytosorbents, GlyCardial Diagnostics and Thromboserin; consultancy fees from Amgen, AstraZeneca, Bayer, Bristol Myers Squibb/Pfizer, Cytosorbents, GlyCardial Diagnostics, Haemonetics, HengRui, Idorsia, PhaseBio, Portola, Sanofi Aventis and Thromboserin; and honoraria from AstraZeneca, Bayer, Bristol Myers Squibb/Pfizer, Intas Pharmaceuticals and Medscape.

Figures

Fig. 1
Fig. 1
Thromboelastography/rotational thromboelastometry tracings
See this image and copyright information in PMC

References

    1. McBane RD, 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, et al. Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo clinic. Mayo Clin Proc. 2020;95(11):2467–2486. doi: 10.1016/j.mayocp.2020.08.030. - DOI - PMC - PubMed
    1. Moutchia J, Pokharel P, Kerri A, McGaw K, Uchai S, Nji M, et al. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS ONE. 2020;15(10):e0239802. doi: 10.1371/journal.pone.0239802. - DOI - PMC - PubMed
    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–2040. doi: 10.1182/blood.2020006000. - DOI - PMC - PubMed
    1. Coronavirus Disease 2019 (COVID-19) treatment guidelines. Available at https://www.covid19treatmentguidelines.nih.gov/ - PubMed
    1. American Society of Hematology. COVID-19 and VTE/anticoagulation: frequently asked questions. Available at https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation